Source: The Lakeside, OR weather data displayed above is derived from the NOAA (National Oceanic and Atmospheric). Air quality and pollution data is derived from the EPA (United States Environmental Protection Agency).
DUBLIN, June 15, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that the 510(k) Premarket Notification Application for the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) has been accepted for filing by the U.S. Food and Drug Administration (FDA).
The use of these bare-metal stents helped reduce the incidence of restenosis from 30â40% in coronary surgery to 20â30%. [citation needed] Though many doctors have created the stent, the first FDA approved stent was invented by Cesare Gianturco and Gary S. Roubin. [citation needed]